Nmda-Receptor 发表于 2025-3-25 06:12:09
https://doi.org/10.1007/978-3-319-19974-0Cytokine disease markers; Lung function; Managment of pneumothorax; Primary health care; Sarcoidosis废止 发表于 2025-3-25 08:46:51
Mieczyslaw PokorskiMedical research into practice.Innovations in diagnostics and treatment of respiratory diseases.Comprehensive accounts of noncommunicable diseases.Focus on population respiratory health废墟 发表于 2025-3-25 14:10:33
http://reply.papertrans.cn/67/6672/667185/667185_23.pngreceptors 发表于 2025-3-25 16:06:04
http://reply.papertrans.cn/67/6672/667185/667185_24.pngconcentrate 发表于 2025-3-25 22:19:01
Brown Adipose Tissue and Browning Agents: Irisin and FGF21 in the Development of Obesity in Childreustify a notion of a role of novel myokines: irisin and fibroblast growth factor 21 (FGF21) in the metabolism and development of obesity. This review describes a possible role of irisin and FGF21 in the pathogenesis of obesity in children.几何学家 发表于 2025-3-26 02:53:08
Book 2015arer than those of inflammatory or infectious background. Such noncommunicable diseases, often entailing genetic and immune aspects, are areas of limited understanding; sarcoidosis being a case in point. This book tackles the issues relevant to such diseases. The research on novel cytokine markers,芭蕾舞女演员 发表于 2025-3-26 06:53:21
http://reply.papertrans.cn/67/6672/667185/667185_27.pngNAIVE 发表于 2025-3-26 09:25:43
http://reply.papertrans.cn/67/6672/667185/667185_28.pngOratory 发表于 2025-3-26 14:46:46
http://reply.papertrans.cn/67/6672/667185/667185_29.png察觉 发表于 2025-3-26 19:22:01
Interleukin-33 as a New Marker of Pulmonary Sarcoidosis,ant contribution of interleukin-33 (IL-33). So far, there are no data about bronchoalveolar lavage fluid (BALF) concentration of IL-33 in patients with BBS. In the present study we attempted to relate the concentration of IL-33 to IL-18, a well-known marker of BBS activity, in BALF of BBS patients.